Clinical Trial Update: Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 1/2 study examining circulating microRNAs in the pathogenesis of systemic lupus erythematosus. The study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: Cairo University | Conditions: Systemic Lupus Erythematosis | Phase 1, Phase 2 | Status: COMPLETED